Redsense Medical AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was SEK 1.28 million compared to SEK 6.12 million a year ago. Negative revenue was SEK 0.157281 million compared to revenue of SEK 6.12 million a year ago. Net loss was SEK 2.37 million compared to SEK 2.55 million a year ago. Basic loss per share from continuing operations was SEK 0.23 compared to SEK 0.18 a year ago.
For the nine months, sales was SEK 8.02 million compared to SEK 10.87 million a year ago. Revenue was SEK 8.72 million compared to SEK 10.87 million a year ago. Net loss was SEK 6.2 million compared to SEK 6.94 million a year ago. Basic loss per share from continuing operations was SEK 0.5 compared to SEK 0.49 a year ago.